Related Experiment Videos
Heterogeneity of plasmids determining high-level resistance to gentamicin in clinical isolates of Streptococcus
Abstract:
Between November 1981 and October 1984, 48 of 3,458 clinical isolates of Streptococcus faecalis at the University of Michigan Hospital showed high-level (greater than 2,000 micrograms/ml) resistance to gentamicin, as well as to all other clinically available aminoglycosides. Thirteen percent of clinical isolates in the University of Michigan Hospital currently demonstrate this level of resistance. Transfer of resistance to a plasmid-free streptococcal recipient was observed in filter matings for 44 of 48 such isolates. Analysis of transconjugants by agarose gel electrophoresis showed that gentamicin resistance was transferred alone in 8 isolates and was combined with other antimicrobial resistances on the same plasmid in the other 36 isolates. There were seven isolates which transferred the property of horse blood beta-hemolysis along with gentamicin resistance. Transfer of gentamicin resistance was either by conjugative plasmids or by a nonconjugative but mobilizable plasmid. Transfer frequencies on filters ranged from 4.7 X 10(-2) to 4.1 X 10(-8). Based on donor and transconjugant antibiotic resistance markers, agarose gel electrophoresis, transfer properties, and restriction enzyme analysis, the plasmid content of transconjugants was heterogeneous and could be classified into at least seven different patterns. These findings argue against clonal dissemination as the cause of the increased frequency of resistant strains and suggest that resistance to gentamicin appears on a variety of physically distinct conjugative and nonconjugative plasmids in S. faecalis.
Insights
High-level gentamicin resistance in Streptococcus faecalis is increasing. Resistance is often plasmid-mediated and appears on diverse plasmids, not solely clonal spread.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- High-level aminoglycoside resistance (HLAR) in Enterococcus faecalis is a growing clinical concern.
- HLAR significantly complicates treatment of serious enterococcal infections.
Purpose of the Study:
- To investigate the prevalence and genetic basis of high-level gentamicin resistance (HLAR) in clinical isolates of Streptococcus faecalis.
- To determine if resistance is associated with specific plasmids or clonal spread.
Main Methods:
- Agarose gel electrophoresis was used to analyze plasmid DNA.
- Filter matings were performed to assess the transferability of resistance.
- Restriction enzyme analysis characterized plasmid heterogeneity.
Main Results:
- 48 of 3,458 isolates (1.4%) showed high-level gentamicin resistance.
- Resistance was transferable via plasmids in 44 isolates.
- Gentamicin resistance was found on diverse, physically distinct plasmids, sometimes with other resistance markers.
Conclusions:
- The increased frequency of gentamicin-resistant S. faecalis is likely due to the acquisition of resistance on various plasmids, rather than clonal dissemination.
- Understanding plasmid-mediated resistance is crucial for managing infections caused by these strains.